X4 Pharmaceuticals
XFOR
XFOR
52 hedge funds and large institutions have $60.1M invested in X4 Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.24% less ownership
Funds ownership: 1.9% → 1.66% (-0.24%)
7% less funds holding
Funds holding: 56 → 52 (-4)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
Holders
52
Holding in Top 10
1
Calls
$271K
Puts
$239K
Top Buyers
| 1 | +$5.77M | |
| 2 | +$5.18M | |
| 3 | +$2.37M | |
| 4 |
LCM
Lynwood Capital Management
Toronto,
Ontario, Canada
|
+$2.14M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.42M |
Top Sellers
| 1 | -$1.88M | |
| 2 | -$1.71M | |
| 3 | -$428K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$258K |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$218K |